Investing Ideas
/
Spanish Healthy high growth potential

Spanish Healthy high growth potential

Results

0 new

Analysts expect these companies to experience strong growth in earnings over the next 3 years. They also meet criteria around being in an acceptable financial position.

2 companies

Pharma Mar

Market Cap: €1.6b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.

PHM

€92.90

2.1%

26.2%

Oryzon Genomics

Market Cap: €220.1m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system), oncology, and hematology disorders.

ORY

€2.84

1.8%

4.4%